University of Colorado Hospital and University of Colorado School of Pharmacy
University of Colorado Anschutz Medical Campus, Aurora, CO
ASHP Accreditation #82012
National Match Service (NMS) Code #666055
This PGY2 residency is designed to develop competencies necessary for specialized practice in infectious diseases pharmacotherapy. The program is individualized to meet needs and interests of the resident. Additional opportunities for participation in clinical research are available. The University of Colorado Hospital and the CU School of Pharmacy are part of the Anschutz Medical Campus of the University of Colorado. PGY2 residents will be involved in teaching programs of the school, including didactic and clerkship teaching of PharmD students and PGY1 residents, as well as medical/surgical residents and fellows. While the program focuses on enhancing clinical skills, a research project is required for successful completion of the residency. Additional clinical research opportunities are available. Additionally, residents will gain experience in teaching, medical writing and publishing. Upon completion of this residency, graduates will be prepared to practice as an infectious diseases pharmacotherapy specialist in either a community or academic environment.
The inpatient and outpatient services of the University of Colorado Hospital provide the primary teaching sites for this program. Other rotation sites may include other hospitals in the Denver area offering unique learning experiences not available at the University of Colorado Hospital.
Rotations are usually scheduled in 4-week increments. Required clinical rotations include two months with the general infectious diseases inpatient consult service, two months of transplant ID consult service, two months of HIV/AIDS & hepatitis, one month of BMT/oncology, and longitudinal experiences in antimicrobial stewardship and the outpatient infectious diseases clinic. A rotation in one of the critical care units of the hospital is also encouraged. Residents will also have opportunities to receive training in basic microbiological techniques and laboratory processes. Possible elective rotations include: infectious diseases at other affiliated hospitals, pediatric ID, adult cystic fibrosis, orthopedic surgical ID service/outpatient antimicrobial therapy (OPAT), research, and others.
Completion of the Colorado Pharmacy Residency Teaching Certificate program is required if completion of a similar program has not already been accomplished during a PGY1 program. Completion of a research certificate program is also required for successful completion of the residency.
REQUIREMENTS: Doctorate of Pharmacy Degree (ACPE accredited program) and PGY1 Pharmacy Residency
PRECEPTORS FOR REQUIRED LEARNING EXPERIENCES:
Douglas Fish, PharmD Clinical Specialist in ID/Critical Care, Residency Program Director
Matthew Miller, PharmD Clinical Specialist in Infectious Diseases/Transplant ID
Jasjit Gill, PharmD Clinical Specialist in Infectious Diseases, HIV/AIDS
Robin Bricker-Ford, PharmD Clinical Specialist in Infectious Diseases, Hepatology and HIV/AIDS
Jayme Arnold, PharmD Clinical Specialist in Infectious Diseases, HIV/AIDS
Gerry Barber, PharmD ID Specialist and Coordinator, UCH Clinical Pharmacy Services
Jeff Kaiser, PharmD Clinical Specialist in BMT/Hematology/Oncology
BENEFITS: PGY2 resident salary is $58,000 per year (estimated 2020-21). Benefits include: healthcare coverage, 23 days annual leave (including meetings and sick days), and a travel stipend. Residents receive an appointment as Clinical Instructor in the School of Pharmacy. Limited staffing (160 hours) is expected of the PGY2 ID residents.
Interested applicants meeting the above criteria should electronically submit a letter of intent, curriculum vitae, academic transcripts, and three letters of recommendation through ASHP’s Pharmacy Online Residency Centralized Application Service (PhORCAS). PhORCAS is the required method of applying for this program. Please contact the Residency Program Director at email@example.com for any questions concerning the application process.
The deadline for receipt of all application materials is no later than January 1, 2020.
This residency site agrees that no person at this site will solicit, accept, or use any ranking-related information from any residency applicant.
Doctor of Pharmacy from an accredited program, PGY1 residency; Colorado licensure
About Skaggs School of Pharmacy and Pharmaceutical Sciences
At the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus, our faculty members are preparing the world’s future pharmacists and pharmaceutical scientists through innovative learning and teaching. Our researchers are leading medical discoveries that advance science and improve health care. We’re enhancing culture and community through programs that reach urban and rural Coloradans. And our collaborations in research, patient care and community service are helping to ensure the health and wellness of Colorado and beyond. Nationally recognized for its leadership in pharmacy education and its strong commitment to developing and sustaining a diverse faculty, staff and student body, the Skaggs School of Pharmacy has achieved many milestones in its 100-plus year history including being ranked in the top 20 percent of all schools of pharmacy in the country, and twelfth in the nation for total NIH funding. Located at the Anschutz Medical Campus, the University of Colorado is the only completely new education, research and patient care facility in the nation today.